» Articles » PMID: 3775237

Increased Mole Fraction of Arachidonic Acid in Bronchial Phospholipids in Patients with Cystic Fibrosis

Overview
Publisher Informa Healthcare
Specialty Science
Date 1986 Oct 1
PMID 3775237
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The fatty acid pattern of the phospholipids in the bronchial secretion of patients with cystic fibrosis (CF) showed an increase of the mole fraction of arachidonic acid (AA) in most phospholipid classes compared to normals. Increase of AA in some classes was also found in patients with chronic bronchitis and in patients chronically colonized with Pseudomonas aeruginosa but in the diphosphatidylglycerol, lysophosphatidylethanolamine and sphingomyelin phospholipids, high fractions of AA was found exclusively in CF patients. Arachidonic acid was found to attain the highest ratios in CF in seven of the nine major bronchial phospholipids compared to the controls. There was no difference in the ratio saturated/unsaturated fatty acids between the CF patients and the control groups. A tendency towards unsaturation of the fatty acids in the bronchial secretion seems to be characteristic of infection and inflammation but AA appears to be more markedly increased in CF. Thus, the recorded changes may be characteristic for CF and not secondary to infection and/or inflammation in general, nor to P. aeruginosa colonization.

Citing Articles

Fatty acid abnormalities in cystic fibrosis-the missing link for a cure?.

Drzymala-Czyz S, Walkowiak J, Colombo C, Alicandro G, Storrosten O, Kolsgaard M iScience. 2024; 27(11):111153.

PMID: 39620135 PMC: 11607544. DOI: 10.1016/j.isci.2024.111153.


Dysregulation of the Arachidonic Acid Pathway in Cystic Fibrosis: Implications for Chronic Inflammation and Disease Progression.

DOrazio S, Mattoscio D Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338347 PMC: 11434829. DOI: 10.3390/ph17091185.


The Omega-6 Lipid pathway shift is associated with neutrophil influx and structural lung damage in early cystic fibrosis lung disease.

Slimmen L, Broos J, Manai B, Estevao S, Giera M, Kooij G Clin Transl Immunology. 2024; 13(9):e70000.

PMID: 39286529 PMC: 11403467. DOI: 10.1002/cti2.70000.


Glued in lipids: Lipointoxication in cystic fibrosis.

Vandebrouck C, Ferreira T EBioMedicine. 2020; 61:103038.

PMID: 33038767 PMC: 7648119. DOI: 10.1016/j.ebiom.2020.103038.


The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide.

Garic D, Dumut D, Shah J, De Sanctis J, Radzioch D Cell Mol Life Sci. 2020; 77(21):4255-4267.

PMID: 32394023 PMC: 11105061. DOI: 10.1007/s00018-020-03530-x.